Brookmont Capital Management Astrazeneca PLC Transaction History
Brookmont Capital Management
- $187 Million
- Q4 2024
A detailed history of Brookmont Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Brookmont Capital Management holds 55,985 shares of AZN stock, worth $3.92 Million. This represents 1.96% of its overall portfolio holdings.
Number of Shares
55,985
Previous 36,158
54.83%
Holding current value
$3.92 Million
Previous $2.82 Million
30.21%
% of portfolio
1.96%
Previous 1.45%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,338Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.41 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.94 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.61 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.58 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.34 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $217B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...